Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Unity Biotechnology, Inc.
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Unity Biotechnology, Inc. since year 2005.
Table 2 shows the detailed insider transactions of Unity Biotechnology, Inc. since 2005.
The reporting company's ticker symbol is UBX. The reporting company's CIK number is 1463361.
The total value of stock buying since 2005 is $0.
The total value of stock sales since 2005 is $0.
The total value of stock option exercises since 2005 is $17,150.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2018-10-10||Goeltz Ii Robert C. (Chief Financial Officer)||Option Ex||5,000||3.43||17,150|
Insider trading activities including stock purchases, stock sales, and option exercises of UBX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Unity Biotechnology, Inc. (symbol UBX, CIK number 1463361) see the Securities and Exchange Commission (SEC) website.